Basic information Uses Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Bromopyridine >  1H-PYRAZOLO[3,4-B]PYRIDINE, 3-BROMO-

1H-PYRAZOLO[3,4-B]PYRIDINE, 3-BROMO-

Basic information Uses Safety Supplier Related

1H-PYRAZOLO[3,4-B]PYRIDINE, 3-BROMO- Basic information

Product Name:
1H-PYRAZOLO[3,4-B]PYRIDINE, 3-BROMO-
Synonyms:
  • 1H-PYRAZOLO[3,4-B]PYRIDINE, 3-BROMO-
  • 3-Bromo-1H-pyrazolo[3,4-b]pyridine ,97%
  • 7-Aza-3-bromo-1H-indazole
  • 3-Bromo-7-azaindazole
  • 3-broMo-2h-pyrazolo[3,4-b]pyridine
  • 3-Bromo-7-aza-1H-indazole
  • 3-Bromo-1H-pyrazolo[3,4-b]pyridine
  • 3-Bromo-1H-pyrazolo[3,4-b...
CAS:
68618-36-0
MF:
C6H4BrN3
MW:
198.02
Mol File:
68618-36-0.mol
More
Less

1H-PYRAZOLO[3,4-B]PYRIDINE, 3-BROMO- Chemical Properties

Melting point:
170-171 °C
Boiling point:
296.9±23.0 °C(Predicted)
Density 
2.00±0.1 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
form 
solid
pka
4.09±0.20(Predicted)
color 
Light yellow
More
Less

Safety Information

Hazard Codes 
T
Risk Statements 
25-20/21/22
Safety Statements 
45-36/37
RIDADR 
UN 2811 6.1 / PGIII
WGK Germany 
3
HS Code 
29339900
More
Less

1H-PYRAZOLO[3,4-B]PYRIDINE, 3-BROMO- Usage And Synthesis

Uses

3-Bromo-1H-pyrazolo[3,4B]pyridine is used as a pharmaceutical intermediate.

Chemical Properties

Light yellow solid

Biological Activity

1H-PYRAZOLO[3,4-B]PYRIDINE, 3-BROMO- is a pyrimidine derivative that acts as a stimulant. It has been shown to cause pulmonary hypertension in rats and has been used to induce pulmonary hypertension in rats. This drug has also been shown to have an effect on the rat heart and is being researched for its biological profiles.

Synthesis

271-73-8

68618-36-0

The general procedure for the synthesis of 3-bromo-1H-pyrazolo[3,4-b]pyridine using 1H-pyrazolo[3,4-b]pyridine as starting material was as follows: bromine (1.91 mL, 37.1 mmol) was slowly added dropwise to a solution of 1H-pyrazolo[3,4-b]pyridine (2.6 g, 21.8 mmol) dissolved in chloroform (100 mL). The reaction mixture was stirred overnight at room temperature. Upon completion of the reaction, the mixture was concentrated to remove the solvent. The concentrated residue was dissolved in a mixture of ethyl acetate (200 mL) and saturated sodium bicarbonate solution (50 mL). The aqueous layer was extracted twice with ethyl acetate (50 mL). All organic layers were combined, dried over anhydrous sodium sulfate, filtered to remove the desiccant, and the filtrate was subsequently concentrated to afford 3-bromo-1H-pyrazolo[3,4-b]pyridine (3.7 g, 86% yield) as a solid product.

References

[1] Patent: WO2009/111279, 2009, A1. Location in patent: Page/Page column 81
[2] Canadian Journal of Chemistry, 1988, vol. 66, # 3, p. 420-428
[3] Patent: WO2012/83117, 2012, A1. Location in patent: Page/Page column 126-127
[4] Patent: WO2018/13867, 2018, A1. Location in patent: Paragraph 506

1H-PYRAZOLO[3,4-B]PYRIDINE, 3-BROMO- Preparation Products And Raw materials

Raw materials

1H-PYRAZOLO[3,4-B]PYRIDINE, 3-BROMO-Supplier

J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Beijing Ouhe Technology Co., Ltd
Tel
010-010-82967028 13522913783
Email
2355560935@qq.com
Jinan Trio PharmaTech Co., Ltd.
Tel
0531-88811783
Email
sales@trio-pharmatech.com
SpringPharma Tech Co.,Ltd
Tel
+86-25-68710855, +86-25-68710897
Email
sales@springpharma.net
Sphinx Scientific Laboratory (Tianjin) Co., Ltd.
Tel
022-66211289-843 13672102692
Email
contact@sphinxpharm.com